The Haemophilia Society led campaign for full access to recombinant Factor 8. Read more about The Haemophilia Society led campaign for full access to recombinant Factor 8.
NICE recommended alpha interferon and ribavirin combination therapy for the treatment of moderate to severe Hepatitis C Read more about NICE recommended alpha interferon and ribavirin combination therapy for the treatment of moderate to severe Hepatitis C
Hepatitis C Strategy for England was published. Read more about Hepatitis C Strategy for England was published.
Ministers in England accepted recommendation for recombinant to be made available for all adult haemophilia patients on a phased basis over a 4-5 year period starting in 2002-03. Read more about Ministers in England accepted recommendation for recombinant to be made available for all adult haemophilia patients on a phased basis over a 4-5 year period starting in 2002-03.
Scotland and Northern Ireland confirmed that all haemophilia patients would be placed on recombinant treatment. Read more about Scotland and Northern Ireland confirmed that all haemophilia patients would be placed on recombinant treatment.
The Secretary of State for Health announced that recombinant products were to be made available for all children under 16 and previously untreated patients in England. Read more about The Secretary of State for Health announced that recombinant products were to be made available for all children under 16 and previously untreated patients in England.
Wales adopted policy of recombinant Factor 8 for all Haemophilia A patients. Read more about Wales adopted policy of recombinant Factor 8 for all Haemophilia A patients.
UKHCDO confirmed recombinant Factor 8 as the safest product available for the treatment of people with bleeding disorders. Read more about UKHCDO confirmed recombinant Factor 8 as the safest product available for the treatment of people with bleeding disorders.
Patients reported difficulties accessing alpha interferon treatment. Read more about Patients reported difficulties accessing alpha interferon treatment.
Alpha interferon was licensed for the treatment of Hepatitis C in the UK. Read more about Alpha interferon was licensed for the treatment of Hepatitis C in the UK.